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Cytotoxic T  cell (To)1 lysis of influenza virus-infected target cells is restricted by the 
major  histocompatibility  locus  and  requires  the  presence  of viral  antigen  on  the 
infected  cell  surface  (1,  2).  A  major  characteristic  of the  T¢  response  to  influenza 
viruses in both mouse and man is its cross-reactivity with serologically distinct type-A 
strains  (3-5).  It has been suggested  that  viral  matrix  (M)-protein,  which is indistin- 
guishable  between  different  type-A viruses,  could  be responsible  for recognition  by 
cross-reactive T~.  This  antigen  was  detected  on the  surface of infected  cells  by sera 
from  animals  hyperimmunized  with  purified  M-protein  (6,  7);  the  assertion  from 
quantitative studies  (8)  was that M-protein constituted a high proportion of the viral 
antigens  expressed  on  abortively  infected  (P815  mastocytoma)  cells.  Because  these 
findings were based  upon  the  use of heterogenous  antisera,  which  reacted  with  M- 
protein, but the specificity of which was not rigorously determined,  we have selected 
a hybridoma that secretes monoclonal antibody to A-virus M-protein for quantitation 
of M-protein on infected cells. In our initial experiments  (9) we found that M-protein 
could be detected on the surface of infected cells, but only in very low amounts;  i.e., 
a  maximum of 2 ×  103 sites/P815 cell infected for 16 h with different type-A viruses. 
In  this  study  we  have  further  examined  the  M-protein  content  of infected  cell 
membranes as well as the kinetics of its appearance.  We find that although the total 
M-protein content of solubilized, isolated plasma membranes is low, virus replication 
is required for its appearance. Approximately  100 times more hemagglutinin than M- 
protein  is  detected  on  abortively  infected  cells  16  h  postinfection.  Neither  the 
monoclonal anti-M  nor the  anti-M-protein  from hyperimmunized  rabbits  blocks T 
cell killing of infected target cells alone or in combination with anti-H-2. Our results 
are discussed in relation to virus protein recognition by T~. 
Materials  and Methods 
Viruses.  Influenza virus strains X-31  (H3N2)  =  A/Hong Kong/1/68  X A/PR/8/34,  A/ 
WSN  (HON1),  A/Japan  305/57  (H2N2),  A/USSR/90/77  (H1N1),  and  B/Hong Kong (B/ 
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1  Abbreviatiom used in this paper: BSA, bovine serum albumin; e.r., endoplasmic reticulum; HA, hemagglu- 
tinin(ation);  Ka, binding affinity constant; M, viral matrix;  PAGE, polyacrylamide gel electrophoresis; 
PBS, phosphate-buffered saline; RIP, radioimmunoprecipitation;  RPMI/10, RPMI-1640 medium that 
contained  10% heat-inactivated fetal calf serum; To, cytotoxic T cell(s). 
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HK)  were cultivated  in embryonated  chicken  eggs, and  virus-containing  allantoic  fluid was 
titrated for hemagglutination  (HA) activity before use. 
To: Generation and Assay.  CBA Tc were generated after intranasal  priming of mice with A/ 
X-31  and  a  secondary  in  vitro  culture  with  A/USSR-infected  lymphoblasts  as  previously 
described  (10).  CBA lymphoblasts  stimulated  for 2  d  with Escherichia  coli  lipopolysaccharide 
served as  target  cells after a  5-h infection with  A/X-31  virus  (for virus infection of cells, see 
below). 51Cr-labeled target cell lysis was assayed  in flat microplates at various ratios of killer: 
target  cells  (11)  for  3  h.  Antisera  were  absorbed  with  B/HK-infected  P815  cells  before 
incubation with the target cells. All wells contained the same volume (0.22 ml). 
Monoclonal  Antibodies.  Hybrid  cell  line  174,  which  forms  antibodies  to  M-protein,  was 
selected after fusion of myeloma cells P3/X-63-Ag8 with immune spleen cells according to the 
method  of K6hler  and  Milstein  (12).  The  spleen  cell  donor  was  a  CBA  mouse  that  was 
immunized with two intramuscular  injections of purified M-protein from A/USSR virus (13) 
in  complete  Freund's  adjuvant.  Fusion  was  carried  out  4  d  after  an  intraperitoneal  boost 
injection (150/xg of M-protein). The hybridoma cells were cloned and grown as solid tumors in 
(CBA  ×  BALB/c)FI  mice. The  specificit3YsOf the antibody  for influenza and  M-protein  was 
established  by  immunoprecipitation  of  S-labeled  virus  proteins  and  polyacrylamide  gel 
electrophoresis. 
Virus  Infection  of Cells.  P815  mastocytoma  cells were  maintained  by  passage  in  (CBA  X 
DBA)F1 mice. In vitro culture done was in RPMI-1640 medium (Grand Island Biological Co., 
Grand  Island,  N.  Y.)  that  contained  10%  heat-inactivated  fetal calf serum  (RPMI/10).  107 
P815  cells were infected with 800  HA U  of influenza virus in  1 ml of RPMI-1640  medium. 
After 1 h at 37°C, the cells were washed and incubated at 2 ×  106/ml in RPMI/10 at 37°C for 
up to 6 h  or at 33°C for 16 h  (10). 
Virus  replication was  prevented  in certain  experiments  by actinomycin  D  (14):  cells were 
preincubated with actinomycin (1 ~g/ml) for 1 h, then infected with A-virus in the presence of 
the inhibitor at  1/lg/ml. Virus was inactivated by UV light: virus (1.5  ml of X-31-containing 
allantoic fluid) was treated  for 4  min at  25 cm from a  Philips 25-W germicidal bulb  (Philips 
Electronic Instruments,  Inc., Mahwah, N. J.). An infectivity check of this UV-treated virus by 
passaging  twice  through  embryonated  chicken  eggs  showed  greatly  reduced  viral  growth; 
however, slight infectivity could still be detected. 
Plasma Membrane Preparations.  The methods of Crumpton and Snary (15)  and Bridgen et al. 
(16)  were  used.  16-h-infected  (X-31)  P815  cells  (109 cells)  were  fractionated  by  differential 
centrifugation  and  discontinuous  sucrose  density  gradients  after  disruption  with  a  Stansted 
pump  (Stansted  Fluid Power Ltd., Essex, England).  Control cells (5 ×  l0  s cells) were infected 
with X-31 virus 1 h before disruption. While endoplasmic reticulum (e.r.) was pelleted, plasma 
membranes were recovered at the 25-36% sucrose-band interface after centrifugation at 22,000 
rpm  for  18 h  in a  Beckman SW41  rotor (Beckman Instruments  Inc., Spinco. Div., Palo Alto, 
Calif.). Membrane fractions were washed and solubilized in 0.25 ml 2% sodium deoxycholate, 
10  mM  Tris,  pH  8.2,  with  phenylmethylsulfonyl  fluoride  present.  M-protein  content  in  the 
lysed membrane fractions was determined by direct, solid-phase microradioimmunoassay. 
Solid-Phase  Radioimmunoassay.  For the detection and quantitation of M-protein or antibodies 
to M-protein flexible plastic plates (Cooke Engineering Co., Alexandria, Va.) were coated with 
purified  M-protein,  detergent-solubilized  membranes,  or  disrupted  virus  according  to  the 
general  procedure  of Rosenthal  et  al.  (17).  Antigens were dried  onto  the wells overnight  at 
37°C,  then  briefly  fixed  with  methanol.  Indirect  binding  assays  used  the  appropriate  12sI- 
labeled goat anti-rabbit  immunoglobulin  or rabbit  anti-mouse  antiserum.  Direct assays were 
with the IgG2 fraction of x25I-labeled monoclonal anti-M antibody. Radiolabeled antisera were 
allowed to react for 15 h at 4°C. The plates were washed, and the wells were separated to count 
the radioactive antibody bound. 
The  M-protein  content  of  purified  membranes  was  quantitated  by  direct  solid-phase 
radioimmunoassay.  Binding  of I2SI-monoclonal  anti-M  to  serial  dilutions  of the  membrane 
lysates  (in  phosphate-buffered  saline  [PBS]/I%  bovine  serum  albumin  [BSA])  and  of the 
purified M-protein  standard  (from  1 mg/ml)  dried  into wells was compared.  The M-protein 
content was estimated on the basis of the standard  M-protein  antibody-binding curve. Three 
sample  dilutions showed a  ~11%  SD of the mean.  Conversion from  the concentration  of M- 1016  INFLUENZA VIRUS ANTIGENS ON  P815  TARGET CELL  SURFACES 
protein (milligrams per milliliter) detected in the solubilized membrane samples to the number 
of molecules per cell was done by the following equation: 
M-protein molecules per cell -- M-protein detected ~g/ml) 
volume solubilized membranes (ml) ×  Avogadro's number  × 
M-protein (/xg/mol) ×  No. cells extracted 
Antibody-binding Studies.  The  IgG2 fraction of the  monoclonal  174  anti-M antiserum was 
purified on a staphylococcal protein-A-Sepharose column (Pharmacia Fine Chemicals, Div. of 
Pharmacia, Inc., Piscataway, N. J.)  according to Ey et al.  (18)  and 125I-labeled  as previously 
described. 28% of the l~SI-antibody bound to M-protein on plastic dishes and wells that were 
coated with detergent-disrupted type-A viruses. Quantitative binding of antibody to cells was 
assayed  as described  before  (19).  P815  cells at  2  ×  105/0.1  ml  (virus-infected or uninfected 
controls)  were  incubated for 90 min at  20°C with  increasing concentrations of radiolabeled 
antibody (2.5  ×  10-3-1  X  10  ~/xg/0.1  ml) in Hepes-buffered RPMI-1640 that contained 1.7% 
BSA and 0.1% NaNa. Cells were washed twice, and radioactivity in the cell pellets was counted. 
Binding data obtained with monoclonal antibody were evaluated by the Scatchard equation 
as described in a previous report (19). A graph of moles of antibody bound per moles of cells vs. 
moles of antibody bound per moles of free antibody ×  moles of cells yielded linear plots with 
a slope equal to the binding affinity constant (Ka) and the x-intercept equal to the number of 
antigenic sites per cell. All quantitation of viral antigens on infected cell surfaces was done by 
Scatchard analysis. 
Expression of HA on infected cells was assayed by monoclonal antisera directed against H 1 
(clone W18/1) or H3 (clone 3/1) of type-A viruses (20, 21). After fractionation on a protein-A- 
Sepharose column, the active IgG2a fractions (determined by HA inhibition titration)  were 
radiolabeled and used in equilibrium binding studies as above. 
Complement-mediated Lysis of Virus-infected Cells.  51Cr-labeled virus-infected cells were  incu- 
bated with diluted antibody for 30 min at 4°C. The cells had been infected for 16 h with A/X- 
31 or B/HK virus. After one wash they were resuspended in 1:1 RPMI-1640 medium with 1% 
fetal  calf serum  guinea pig complement  (absorbed  with  agarose,  diluted  1:3  in  PBS)  and 
incubated at  37°C  for  1 h.  Cells were  then  pelleted by centrifugation, and aliquots of the 
supernates were counted for radioactivity. All antisera used had been previously absorbed with 
B/Hong Kong-infected target cells. 
Preparation of Labeled Virus Antigens.  Primary chick embryo fibroblasts were infected with A/ 
WSN/33  (HOH1)  influenza virus. The virus was adsorbed for 30 min and then replaced with 
minimal  essential  medium  that  contained  70  /.tCi  of  [L-35S]methionine  (1,270  Ci/mmol) 
(Amersham Corp., Arlington Heights, Ill.) per milliliter. The cultures were incubated at 37°C 
for 48 h, and the labeled virus was purified by velocity centrifugation. Labeled virus was lysed 
in  0.05  M  Tris-HCl  (pH  7.5),  0.6  M  KCI,  and  0.5%  Triton  X-100  (Rohm  and  Haas, 
Philadelphia, Pa.)  for 30 min at 25°C. Protein aggregates were removed by centrifugation at 
150,000 g for 45 min. 
Immunoprecipitation.  200/d of hybridoma tissue culture fluid was added to  100 ~l of normal 
mouse serum (1/400)  in radioimmunoprecipitation (RIP)  buffer (0.05 M  Tris-HCl [pH 8.0.], 
1 mM EDTA, 0.15 M  NaCI, and 0.25% BSA) with  100 ~1 of labeled viral antigens diluted to 
50,000 cpm/100/~1. The reaction mixture was incubated for 2 h at 25°C and then centrifuged 
at 800 g for 15 rain. This was necessary to prevent labeled M-protein from adhering nonspecif- 
ically to precipitates. 50 btl of a  1/5 dilution of a  rabbit anti-mouse Ig mixture was incubated 
for 2 h at 25°C, then overnight at 4°C. Precipitates were washed three times with RIP buffer 
and  dissolved  in  25  /zl  of  polyacrylamide  gel  electrophoresis  (PAGE)  sample  buffer  that 
contained 10% 2-mercaptoethanol. Immunoprecipitates were analyzed by 8% sodium dodecyl 
sulfate-PAGE as described by Laemmli  (22)  for  15  h  at  70  V.  The  gels were  processed  for 
fluorography and exposed to Kodak XR-5 film (Eastman Kodak Co., Rochester, N. Y.) for 20 
h. 
Results 
Specificity  of Monoclonal  Antibodies to M-Protein.  The monoclonal anti-M  (174)  is an 
IgG2  antibody  and  can  be  efficiently  fractionated  on  staphylococcal  protein-A- HACKETT,  ASKONAS,  WEBSTER,  AND  VAN  WYKE  1017 
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Fxc.  1.  Fractionation ofmonoclonal anti-M-protein antiserum on staphylococcal protein-A-Seph- 
arose. Immunoglobulin fractions sequentially eluted from the protein-A column were titrated for 
anti-M-protein activity by indirect solid-phase radioimmunoassay. Bound monoclonal antibody was 
detected by mSI-labeled rabbit anti-mouse F(ab')2. Antibody binding to purified A-virus M-protein: 
(0) unfractionated  174 serum; (V)  174 serum components not adsorbed to protein-A column (fall 
through); (&) IgG2 fraction from 174; (m) IgG1 fraction from 174; (t--A) normal mouse serum, 1/100 
dilution. Antibody binding to disrupted B/Hong Kong virus: ((~) 174 serum. 
Sepharose columns (Materials and Methods). The resulting antibody fraction interacts 
with M-protein of influenza virus A/X-31, but not with that of B/HK (Fig.  1). It has 
equally high reactivity with all other type-A viruses tested (USSR, A/Jap/Bel, WSN, 
and Jap 305;  data  not  illustrated).  The antibody specificity was verified by immu- 
noprecipitation of ~S-labeled viral proteins and PAGE. Fig. 2 shows that reaction of 
the monoclonal antibody is restricted to M-protein alone. 
Quantitation of M-Protein  in  Solubilized  Membranes  Purified from  A/X-31  Virus-infected 
P815 Cells.  Because our antibody is monoclonal it was important  to ascertain that 
the low number of M-protein sites detected on the surface of infected cells could not 
simply be attributed  to the possibility that the antibody interacts with a  part of the 
M-protein molecule that is poorly accessible on intact cells. For this reason we purified 
plasma  membranes  and  e.r.  from  P815  cells  infected  16  h  with  X-31  virus  and 
estimated the content of membrane-associated M-protein in detergent lysates, which 
would include both surface and internal M-protein. Cells in contact with the virus  1 
h,  without  further  virus  replication,  served  as  control.  Radioimmunoassay  of the 
solubilized fractions (Fig.  3) shows that membranes isolated from  16-h-infected cells 
bind small but  significant  amounts of lZ~I-monoclonal anti-M,  whereas control cell 1018  INFLUENZA VIRUS ANTIGENS  ON  P815 TARGET CELL SURFACES 
Frc. 2.  Specific  immunoprecipitation of M-protein by monoclonal antibody  174. The 35S-labeled 
A/WSN virus proteins resolved in this fluorogram are: (lane 1) radiolabeled whole virus used in 
immunoprecipitation;  (lanes 2 and 3) precipitate by culture supernates of hybrid cells 174; (lane 4) 
precipitation with parental  P3X63-Ag8 culture supernate only. P1.2.3, polymerases; NP, nucleopro- 
tein; NA, neuraminidase. 
membranes bind  about  the same low level  as disrupted  type-B virus.  By comparing 
several  dilutions  of the  membrane  samples  (1/5,  1/10,  1/40  for  the  e.r.;  1/10  and 
1/20  for plasma  membrane)  with  corresponding points  on  the  standard  M-protein 
titration curve, we estimate that there is a total content of ~ 1.3 ~g of M-protein in the 
e.r.  fraction  and  0.8 ~g of M-protein  in  plasma  membranes  derived  from  109  16-h- 
infected cells.  This corresponds  to  1.9  ×  104 molecule/cell  in  the plasma membrane 
and 3.1  ×  104 molecule/cell  in the e.r.  (see Materials  and Methods for calculation), 
ls  Virus Replication  Required for the Appearance of Cell Surface M-Protein?  We studied 
the kinetics of cell surface M-protein in relation to virus replication (Table I). Whereas 
the binding of 125I-anti-M-protein  to cells infected  overnight with  A/X-31  gave the 
usual  result  of showing -1.6  ×  103 M-protein  site/cell,  cells treated  overnight  with 
A/X-31  inactivated  by UV irradiation,  or with  infectious A/X-31  in the presence of HACKETT,  ASKONAS,  WEBSTER,  AND VAN WYKE  1019 
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Quantitation of M-protein in lysates of X-31 virus-infected P815 cell membranes by solid- 
phase  radioimmunoassay.  Membranes  were  purified  from  16-h infected  cells and  control  cells 
(infected 1 h before disruption) and solubilized in deoxycholate. Wells were coated with the lysates, 
and the amount of M-protein was determined by direct binding of ]Z~l-monoclonal  anti-M antibody. 
Radioactivity of antibody (cpm) bound to: (O) plasma membrane,  16-h-infected cells; (&) e.r., 16- 
h-infected cells; (O) plasma membrane, control cells; (A) e.r., control cells; (1"1) purified M-protein 
standard; (11) solubilized A/X-31 virus (600 HA U/25 #1); (×) solubilized B/Hong Kong virus (300 
HA U/25/tl). 
actinomycin  D  to  prevent  virus replication  (14),  showed  far  less antibody binding. 
The transient low binding of anti-M-protein soon after cell treatment (which suggested 
<  100 M-protein sites) can probably be assigned to rupture of virus, because after 16 
h  of incubation  there  was  no  detectable specific binding  of anti-M.  Although  the 
number of M-protein sites on the surface of cells infected for  16 h  is only -108, virus 
replication  is  required  for  the  appearance  of M-protein,  and  it  does  appear  to  be 
synthesized by the host cell. 
Expression  of HA  on  Virus-infected  Cells.  We  measured  viral  HA  on  16-h  infected 
cells to  confirm  that  our  conditions of infection  and  incubation  permitted  normal 
expression  of virus  proteins  on  the  cell surface.  Quantitative  binding  studies  with 
radiolabeled monoclonal antibodies (Table II)  show a  high  number  of HA sites on 
cells infected  with  different  type-A viruses.  The  2.75  ×  105  molecules/cell seen  in 
USSR-infected P815  cells and  1.2  ×  105  sites/X-31-infected cell are approximately 
two orders of magnitude higher than  the amount  of M-protein detected on  the cell 
surface in similar infections. 
Does  Antibody  to  M-Protein  Block  T  Cell-mediated  Cytotoxicity?  If  M-protein  were 
recognized by cross-reactive Tc we would expect  inhibition of cell-mediated lysis of 1020  INFLUENZA VIRUS  ANTIGENS ON  P815 TARGET CELL SURFACES 
TABLE  I 
Virus Replication is Required  for the Appearance of Cell Surface M-Protein 
Time of incu-  Surface  M-  Infection  bation  protein 
Infectious A/X-31 virus 
UV light-inactivated A/X-31 virus 
Actinomycin D and infectious A/X-31 vi- 
rus 
h  site~cell 
0.5  0* 
3  100:~ 
16  1,600§ 
0.5  0 
3  100~ 
16  0 
0.5  80~ 
3  0 
16  0 
* Indicates no binding  of 125I-anti-M  above background binding  to uninfected 
cells. 
:~ The very low values  are derived from the amounts of 12~I-antibody  specifically 
bound  per cell at  saturation,  where binding below saturation  level was 
insufficiently  above background for evaluation by Scatchard analysis. 
§ M-protein sites are assayed by binding of 12%monoclonal  antibody to M- 
protein on infected P8 15 cells over a wide range of antibody concentrations; 
the number of sites obtained  by extrapolation of Scatchard plots of the 
binding data (9). 
TABLE  II 
Expression of Viral HA by P815 Cells Infected  for 16 h with Type-A 
Influenza  Virus 
125I-Labeled monoclonal  Infection  HA  antibody 
molecule~cell  * 
A/X-31  3/1 (anti-H3)  1.2 X 105 
A/USSR  W18/1 (anti-HI)  2.7 X 10  ~ 
• Estimate from Scatchard plots of l~I-antibody-binding data. 
influenza virus-infected target cells by an excess of antibody. Neither the monoclonal 
nor the heterogeneous antibodies to M-protein blocked T  cell cytotoxicity either alone 
or in the presence of monoclonal antibodies to H-2  (30R3)  (kindly donated by Dr. 
Lemke, University of Cologne, Cologne, Federal Republic of Germany) (Table III). 
The monoclonal anti-H-2 on its own partially inhibits cytotoxicity, but this inhibition 
is not enhanced by anti-M. 
Complement-mediated Lysis of A-Virus-infected Cells by Antibodies  to  Viral Proteins.  P815 
cells were infected overnight with A/X-31, and complement-mediated lysis by mon- 
oclonal and  heterogeneous antisera from  rabbits hyperimmunized with  M-protein 
was assayed. Cell lysis was observed with rabbit antiserum to M-protein, even after 
absorption of the  serum  with  B/HK-infected P815  cells.  On  the  other  hand,  the 
monoclonal anti-M-protein failed to effect lysis of infected cells, although the antibody 
174 is an IgG2a, which should fix complement (Fig. 4). This finding does not permit 
final conclusions. It could be a result of the low number of M-protein sites on infected 
cells  or  of the  fact  that  monoclonal antibodies do  not  necessarily lyse  cells  with 
complement. We obtained similar results with monoclonal anti-HA antibodies. IgG2a HACKETT,  ASKONAS,  WEBSTER,  AND  VAN  WYKE 
TABLE  III 
Antibody to M-Proteins Does Not Inhibit  T Cell Killing of Virus-infected 
Targets 
1021 
Treatment of target cells 
Percentage of control cyto- 
toxicity 
4*  8* 
--  100 
Normal mouse serum (1/100)  96 
Anti-nucleoprotein (clone 150/7)  (1/100)  97 
174 anti-M-protein (1/100)  100 
174 anti-M-protein (1/50)  98 
30 R3-anti-H-2 (1/100)  68 
30 R3-anti-H-2 and 174 anti-M (1/100)  67 
Rabbit anti-M (1/50)  97 
Rabbit anti-M and 30 R3 (1/100)  65 
100 
98 
98 
97 
108 
77 
75 
103 
78 
* 3-h 5]Cr-release assay yielded 25 and 39% virus-specific killing at killer:target 
cell ratios of 4 and 8, respectively. CBA cytotoxic cells induced in vitro with 
A/USSR-infected lymphoblasts (4). CBA lymphoblasts infected with A/X- 
31  virus served as target cells. Target cells were pretreated with antisera for 
30 rain before addition of cytotoxic cells. 
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Fro.  4.  Lysis of virus-infected P815 cells by antibody to viral proteins and complement. Cells were 
infected for 16 h with A/X-31 virus or B/HK and labeled with 51Cr. The dotted line indicates the 
level of background 51Cr release. Lysis (radioactivity released) by the following antibodies: A/X-31- 
infected target cells: (0)  74/6 anti-HA H3(IgM);  (,&) 3/1  anti-HA H3(IgG2a);  (V) hyperimmune 
rabbit anti-M;  (ll)  monoclonal anti-M  174  (IgG2).  B/HK-infected cells:  ((3) 74/6;  (A)  3/1;  (V) 
rabbit anti-M; ([]) monoclonal anti-M 174. 1022  INFLUENZA  VIRUS ANTIGENS ON P815 TARGET CELL SURFACES 
monoclone 3/1 does not lyse infected cells in the presence of guinea pig complement, 
although  125I-labeled  3/1  antibody  does  bind  to  A/X-31-infected  cells.  An  IgM 
monoclonal  antibody  to  HA  (74/6)  was  efficient  in  complement-mediated  lysis. 
Howard  and  Corvalan  (23)  also  found  that  not  all  monoclonal  antibodies  to  rat 
histocompatibility antigens, though able to fix complement, will lyse cells. 
Discussion 
Accurate  quantitation  of  M-protein  on  influenza  virus-infected  target  cells  is 
important  for assessment of the role of that antigen  in recognition by cross-reactive 
To. We have recently selected a  hybridoma secreting monoclonal  anti-M to pursue 
this  question.  The  monoclonal  anti-M-protein  antibody  174  has  the  advantage  of 
monospecificity, which  could not  be fully ascertained  with heterogeneous hyperim- 
mune antisera used in the past. The monoclonal serum shows no cross-reactivity with 
other A-virus proteins or with cells infected with type-B influenza viruses. In addition, 
the high-titer hybridoma serum can be readily purified to yield an IgG2 fraction of 
high  antibody  content  and  a  Ka  of  1-2  ×  109  liter/mol  (9),  thereby  facilitating 
quantitative binding studies. 
In our preliminary studies (9) we detected very low levels of specific binding of the 
monoclonal anti-M  to P815  cells infected up to  16 h  with  different  type-A viruses. 
Only  when  nonspecific  binding  was  deducted  could  saturation  of M-sites  by  the 
antibody become evident.  Scatchard plots of the binding data showed that a  maxi- 
mum of 2-3 ×  103 M-protein molecules appear on each P815 cell surface infected for 
16 h with different type-A viruses. This is much lower than the 105-106 sites estimated 
by Ada and Yap (8).  Our figure does not result from any generally reduced protein 
synthesis under our infection conditions, because high levels of HA expression (>105 
molecule/surface of each cell)  were readily obtained;  and, typically, 65-75% of the 
infected P815 cells can be lysed specifically by Tc (10). 
Another possibility, that the epitope on the M-protein detected by our monoclonal 
anti-M is poorly accessible on the cell surface, is ruled out by studies with solubilized, 
purified cell membranes. In the lysates, all M-protein molecules (internal and external) 
should  be  available  to  the  antibody,  yet  we  do  not  see  the  two  to  three  order  of 
magnitude  increase  that  would  be  suggested  by  the  values  of Ada  and  Yap  (8). 
Instead, radioimmunoassay detected  the equivalent  of ~ 1.9  ×  104  molecule/cell  in 
the  plasma  membrane  lysate,  and  3.1  ×  104  molecule/cell  in  the  e.r.  fraction. 
Adjustment of these values for estimated recovery of total membrane protein increases 
the  figures to  ~3.8  ×  104  and  6.2  ×  104  molecule/cell in  these respective fractions, 
assuming a  50%  yield  as suggested  by the  data of Crumpton  and  Snary  (15)  with 
<1010  Bristol-8  lymphoblastoid  cells.  Our  samples  (5  ×  108  and  10  9  cells)  were 
disrupted  and purified according to their procedures. The  10- or 20-fold higher M- 
content  of lysed plasma membranes compared with  infected cells is consistent with 
the view  (24)  that  M-protein is localized principally on the cytoplasmic side of the 
host cell plasma membrane. M-protein is also found in internal membrane fractions 
(24), as is the case in our e.r. fraction. Because only a small fraction of the M-protein 
associated with plasma membranes is found on the surface of the P815 cells even after 
a  long period  of infection,  we examined  the  possibility that  the  surface  M-protein 
might  have  originated  from  ruptured  input  virus  that  was exposed  on  the  cell 
membrane as incubation progressed. Our findings with actinomycin D treatment and HACKETT, ASKONAS, WEBSTER, AND VAN WYKE  1023 
UV-inactivated virus show  that  virus replication  is indeed  required  for cell surface 
M-protein appearance. This, and evidence from kinetic studies of M-protein appear- 
ance on infected P815 cells (9), indicate that the external M-protein detected in these 
studies is synthesized within the host cell. However, we have no direct evidence that 
M-protein  is  expressed  as  a  membrane  protein  in  the  same sense  as  for the  viral 
glycoproteins. The possibility remains that some slight  amount of virus budding or 
rupture of partially assembled virions could be the source of the surface M-protein. 
The study of complement-mediated lysis of infected target cells with monoclonal 
antisera of viral protein was inconclusive. Monoclonal anti-M-protein did not promote 
lysis, even though  it is of the IgG2 class and should be capable of fixing guinea pig 
complement. Although  we know that >10  s HA molecules are expressed on the cell 
surface, the monoclonal anti-HA 74/6  (IgM) was effective, whereas the 3/1 anti-HA 
(IgG2a)  killed  only  very  slightly,  if at  all  (Fig.  4).  It  is  clear  that  complement- 
dependent  lysis  is  less  sensitive  than  antibody-binding  studies  in  detection  of cell 
surface antigens,  that  monoclonal  antibodies,  in  particular,  vary in  their ability to 
cause complement-mediated cell lysis as reported by Howard and Corvalan  (23).  In 
confirmation of earlier results by Biddison et al.  (6), our studies with hyperimmune 
rabbit  anti-M  (which  had been preabsorbed by B/Hong Kong-infected P815  cells) 
showed that it could bind to and promote complement-mediated lysis of 16-h A-virus- 
infected P815 cells. However, because of the heterogeneous nature of this antiserum, 
lysis  of  infected  targets  is  not  adequate  proof that  M-protein  is  integrated  as  a 
membrane protein in the host cell surface. The use of such a  heterogeneous serum is 
the  most  likely explanation  of the  estimates  of Ada  and  Yap  (8),  which  differ so 
markedly from ours. Because the specificities of heterogeneous antibodies are not well 
defined  (and  might  not  be detected  by immunodiffusion  tests),  possible low cross- 
reactivity  with  other  virus  components  or  antigens  on  infected  cells  cannot  be 
completely ruled out. Ada and Yap (8)  reported it difficult to purify antibody from 
the hyperimmune antisera (anti-M-protein or anti-HA) and therefore found <2% of 
added radioactivity bound to infected cells. In contrast, our radiolabeled monoclonal 
probes all  showed  a  minimum  of 20%  binding  under  conditions  of antigen  excess. 
Finally,  our  quantitation  of  surface  viral  antigens  is  by  extrapolation  of  linear 
Scatchard plots of the antibody-binding data to saturation, which is an analysis that 
requires monoclonal antibody (19). 
The central question regarding the possible recognition of M-protein by Tc cross- 
reactive  for  different  type-A  influenza  viruses  is  not  yet  resolved.  P815  cells  are 
excellent target cells for T  cell lysis after a 3- or 16-h infection period. After 3 h, only 
102 M-protein sites can be detected on infected P815 cells (9). We do not know how 
many antigenic  sites are required  to induce  T  cell  killing.  On  the other hand,  our 
findings concerning the low numbers of M-protein sites exposed on cells and the lack 
of inhibition of T  cell cytotoxicity by antibodies to M-protein even in the presence of 
anti-H-2  leave  in  doubt  that  it  is  the  M-protein  that  is  recognized  by To.  Other 
evidence is accumulating that suggests that the cross-reactive T~ may have specificity 
for the homologous part of the HA molecules. Effros et al. (26) have provided evidence 
of the inhibition  of T~ specific for the different subtypes of A-virus by antibodies to 
HA. We find that some (but not all) monoclonal antibodies to HA of type-A virus in 
combination  with  monoclonal  antibodies  to  H-2  synergistically  inhibit  T  cell-me- 
diated lysis of infected target cells (25). 1024  INFLUENZA VIRUS  ANTIGENS ON  P815 TARGET CELL SURFACES 
Summary 
Monoclonal  antibody  to  type-A influenza  virus  matrix  (M)-protein  was  used  to 
quantitate the appearance of M-protein on abortively infected P815 cells. After 16 h 
of infection with different type-A viruses, only a  low amount of M-protein appears on 
the  surface  of  infected  cells  (~103  site/cell)  in  contrast  to  ~105  hemagglutinin 
molecules on each cell surface.  However, virus replication is required for M-protein 
appearance. Analysis of solubilized membranes purified from 16-h-infected cells shows 
~104  M-protein molecule/cell in the plasma membrane,  a  content  that is consistent 
with  the  observed  low  surface  expression,  and  that  indicates  that  most  of the  M- 
protein is localized internally. We found no evidence that cross-reactive cytotoxic T 
cells could recognize M-protein; neither monoclonal antibody nor hyperimmune anti- 
M-protein antiserum could inhibit T  cell killing, either alone or in combination with 
monoclonal anti-H-2 antibody. Taken together, the low level of M-protein appearance 
and lack of T  cell blocking by anti-M-protein antibody leaves doubt that M-protein 
is the antigen recognized by cross-reactive cytotoxic T  cells. 
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